FDA Inspection 1019952 — C&T Dream Co., Ltd.

C&T Dream Co., Ltd. — FEI 3012668529

The FDA completed an inspection of C&T Dream Co., Ltd. on Jul 21, 2017 in Cheonan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cheonan (Korea (the Republic of))

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
184221 CFR 211.84(d)(1)Component identity verification
192721 CFR 211.166(b)Accelerated stability studies
360921 CFR 211.160(b)(2)In-process sample representation/identification
361021 CFR 211.160(b)(3)Drug product sample
436821 CFR 211.188(b)(12)Investigations made into any unexplained discrepancy

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.